Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei
The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (ac...
Gespeichert in:
Veröffentlicht in: | Journal of antimicrobial chemotherapy 2009-06, Vol.63 (6), p.1293-1295 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1295 |
---|---|
container_issue | 6 |
container_start_page | 1293 |
container_title | Journal of antimicrobial chemotherapy |
container_volume | 63 |
creator | Steverding, Dietmar Wang, Xia |
description | The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT. |
doi_str_mv | 10.1093/jac/dkp120 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21012361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jac/dkp120</oup_id><sourcerecordid>1710171381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</originalsourceid><addsrcrecordid>eNp90U1rFTEUBuAgir2tbvwBMgi6EMaefN9ZammtUnBhleImZDKZmntnkjFnRtp_b2QuCi5c5UAeXg7nJeQZhTcUGn66s-6020-UwQOyoUJBzaChD8kGOMhaC8mPyDHiDgCUVNvH5Ig2nCsh5YYM5z_tsNg5pFilvrJxDjUO3k8h3tYY3D56xKrLyy2Wz66a05QCptFni74K8Xtow5wylrFyaWxDPGTF6jrfTzamgm3V5sX58IQ86u2A_unhPSFfLs6vzy7rq0_vP5y9vaqdEHque6BlOcW3DbRaANeSUQ0MeumdpL6RW6aazlLhgUmqXNuC66V1oufCdUzxE_JqzZ1y-rF4nM0Y0PlhsNGnBQ2jQBlXtMAX_8BdWnIsuxWj1ZaD1gW9XpHLCTH73kw5jDbfGwrmdwGmFGDWAgp-fkhc2tF3f-nh4gW8XEFapv8H1asLOPu7P9LmvVG6nMRc3nwzny_Y13cfb6QR_Bee6Z4f</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217683077</pqid></control><display><type>article</type><title>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Steverding, Dietmar ; Wang, Xia</creator><creatorcontrib>Steverding, Dietmar ; Wang, Xia</creatorcontrib><description>The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkp120</identifier><identifier>PMID: 19336455</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Animals ; Antimicrobial agents ; Antiprotozoal Agents - pharmacology ; Chemotherapy ; DNA topoisomerase inhibitors ; drug combinations ; Drug Synergism ; Enzyme Inhibitors - pharmacology ; Humans ; Inhibitor drugs ; Inhibitory Concentration 50 ; Parasitic diseases ; Parasitic Sensitivity Tests ; Pharmacology ; T. brucei ; Trypanosoma brucei ; Trypanosoma brucei brucei - drug effects</subject><ispartof>Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1293-1295</ispartof><rights>The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2009</rights><rights>The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</citedby><cites>FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19336455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steverding, Dietmar</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><title>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT.</description><subject>Animals</subject><subject>Antimicrobial agents</subject><subject>Antiprotozoal Agents - pharmacology</subject><subject>Chemotherapy</subject><subject>DNA topoisomerase inhibitors</subject><subject>drug combinations</subject><subject>Drug Synergism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Inhibitor drugs</subject><subject>Inhibitory Concentration 50</subject><subject>Parasitic diseases</subject><subject>Parasitic Sensitivity Tests</subject><subject>Pharmacology</subject><subject>T. brucei</subject><subject>Trypanosoma brucei</subject><subject>Trypanosoma brucei brucei - drug effects</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90U1rFTEUBuAgir2tbvwBMgi6EMaefN9ZammtUnBhleImZDKZmntnkjFnRtp_b2QuCi5c5UAeXg7nJeQZhTcUGn66s-6020-UwQOyoUJBzaChD8kGOMhaC8mPyDHiDgCUVNvH5Ig2nCsh5YYM5z_tsNg5pFilvrJxDjUO3k8h3tYY3D56xKrLyy2Wz66a05QCptFni74K8Xtow5wylrFyaWxDPGTF6jrfTzamgm3V5sX58IQ86u2A_unhPSFfLs6vzy7rq0_vP5y9vaqdEHque6BlOcW3DbRaANeSUQ0MeumdpL6RW6aazlLhgUmqXNuC66V1oufCdUzxE_JqzZ1y-rF4nM0Y0PlhsNGnBQ2jQBlXtMAX_8BdWnIsuxWj1ZaD1gW9XpHLCTH73kw5jDbfGwrmdwGmFGDWAgp-fkhc2tF3f-nh4gW8XEFapv8H1asLOPu7P9LmvVG6nMRc3nwzny_Y13cfb6QR_Bee6Z4f</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Steverding, Dietmar</creator><creator>Wang, Xia</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20090601</creationdate><title>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</title><author>Steverding, Dietmar ; Wang, Xia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antimicrobial agents</topic><topic>Antiprotozoal Agents - pharmacology</topic><topic>Chemotherapy</topic><topic>DNA topoisomerase inhibitors</topic><topic>drug combinations</topic><topic>Drug Synergism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Inhibitor drugs</topic><topic>Inhibitory Concentration 50</topic><topic>Parasitic diseases</topic><topic>Parasitic Sensitivity Tests</topic><topic>Pharmacology</topic><topic>T. brucei</topic><topic>Trypanosoma brucei</topic><topic>Trypanosoma brucei brucei - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steverding, Dietmar</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steverding, Dietmar</au><au>Wang, Xia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>63</volume><issue>6</issue><spage>1293</spage><epage>1295</epage><pages>1293-1295</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>19336455</pmid><doi>10.1093/jac/dkp120</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-7453 |
ispartof | Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1293-1295 |
issn | 0305-7453 1460-2091 |
language | eng |
recordid | cdi_proquest_miscellaneous_21012361 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | Animals Antimicrobial agents Antiprotozoal Agents - pharmacology Chemotherapy DNA topoisomerase inhibitors drug combinations Drug Synergism Enzyme Inhibitors - pharmacology Humans Inhibitor drugs Inhibitory Concentration 50 Parasitic diseases Parasitic Sensitivity Tests Pharmacology T. brucei Trypanosoma brucei Trypanosoma brucei brucei - drug effects |
title | Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A20%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20anti-sleeping-sickness%20drugs%20and%20topoisomerase%20inhibitors%20in%20combination%20on%20Trypanosoma%20brucei&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Steverding,%20Dietmar&rft.date=2009-06-01&rft.volume=63&rft.issue=6&rft.spage=1293&rft.epage=1295&rft.pages=1293-1295&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dkp120&rft_dat=%3Cproquest_cross%3E1710171381%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217683077&rft_id=info:pmid/19336455&rft_oup_id=10.1093/jac/dkp120&rfr_iscdi=true |